ISDA

Deposition Date 2008-11-13

Release Date 2009-06-23

Last Version Date 2024-10-16

Entry Detail

PDB ID:

3F8S

Keywords:

HYDROLASE

Title:

Crystal structure of dipeptidyl peptidase IV in complex with inhibitor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.43 Å

R-Value Free:

0.29

R-Value Work:

0.24

R-Value Observed:

0.24

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Dipeptidyl peptidase 4
Gene (Uniprot):DPP4
Chain IDs:A, B
Chain Length:748
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P27487 Pfam ID:PF00930, PF00326 EC:3.4.14.5

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
ASN	A	ASN	GLYCOSYLATION SITE

Ligand Molecules

NAG

PF2

Primary Citation

(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor.

Ammirati, M.J, Andrews, K.M, Boyer, D.D, Brodeur, A.M, Danley, D.E, Doran, S.D, Hulin, B, Liu, S, McPherson, R.K, Orena, S.J, Parker, J.C, Polivkova, J, Qiu, X, Soglia, C.B, Treadway, J.L, VanVolkenburg, M.A, Wilder, D.C, Piotrowski, D.W.Show

Bioorg.Med.Chem.Lett. 19 1991 1995 (2009)

PMID: 19275964 DOI: 10.1016/j.bmcl.2009.02.041

Abstact

A series of 4-substituted proline amides was synthesized and evaluated as inhibitors of dipeptidyl pepdidase IV for the treatment of type 2 diabetes. (3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone (5) emerged as a potent (IC(50) = 13 nM) and selective compound, with high oral bioavailability in preclinical species and low plasma protein binding. Compound 5, PF-00734200, was selected for development as a potential new treatment for type 2 diabetes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures